Benefits of Glucagon-Like Peptide-1 Agonists Use in Patients With Inflammatory Bowel Disease

被引：0
|
作者：
Abboud, Alan [1 ]
Aksan, Feyzullah [2 ]
Monzur, Farah [3 ]
机构：
[1] Stony Brook Univ Hosp, Ramsey, NJ USA
[2] SUNY Stony Brook, Renaissance Sch Med, Port Jefferson Stn, NY USA
[3] SUNY Stony Brook, Renaissance Sch Med, Stony Brook, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001034412.42810.c5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1261
引用
收藏
页码：S899 / S899
页数：1
相关论文
共 50 条
  • [21] Glucagon-like peptide-1 Receptor Agonists as Potential Treatments for Inflammatory Myopathies
    Alruwaili, F.
    Lalani, E.
    Raheem, A.
    Raji, M.
    Murthy, V.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S317 - S317
  • [22] Successful Use of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Short Gut Syndrome in Patients With Inflammatory Bowel Disease
    Darlington, Kimberly C.
    Kakadiya, Payal
    Herfarth, Hans
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (12S): : S26 - S26
  • [23] Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
    Al-Badri, Marwa R.
    Azar, Sami T.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2014, 5 (02) : 34 - 38
  • [24] Perioperative management of patients on glucagon-like peptide-1 receptor agonists
    Mizubuti, Glenio B.
    Ho, Anthony M. -H.
    da Silva, Leopoldo Muniz
    Phelan, Rachel
    CURRENT OPINION IN ANESTHESIOLOGY, 2024, 37 (03) : 323 - 333
  • [25] Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics
    Delgado, A.
    Velosa, J.
    Avelar, R.
    Franco, J.
    Heitor, M.
    EUROPEAN PSYCHIATRY, 2021, 64 : S775 - S775
  • [26] Glucagon-like peptide-1 receptor agonists as anti-inflammatory agents: A potential mode of cardiovascular benefits
    Salem, Ahmed M.
    Bain, Stephen C.
    Obaid, Daniel R.
    ATHEROSCLEROSIS, 2022, 352 : 83 - 84
  • [27] Renal Benefits of Glucagon-Like Peptide-1 Receptor Agonists After Kidney Transplantation
    Sahi, S.
    Lemke, A.
    Duffy, D.
    Smith, B.
    Budhiraja, P.
    Diwan, T. S.
    Stegall, M. D.
    Denic, A.
    Wadei, H.
    Park, W.
    Abdelrheem, A. A.
    Shah, P.
    Kudva, Y. C.
    Kukla, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S563 - S564
  • [28] Use of Glucagon-Like Peptide-1 Agonists to Improve Islet Graft Performance
    Yong Wang
    Meirigeng Qi
    James J. McGarrigle
    Brian Rady
    Maureen E. Davis
    Pilar Vaca
    Jose Oberholzer
    Current Diabetes Reports, 2013, 13 : 723 - 732
  • [29] Glucagon-Like Peptide-1 Receptor Agonists-Use in Clinical Practice
    Trico, Domenico
    Solini, Anna
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2021, 28 (04) : 328 - 336
  • [30] Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease A Review
    Honigberg, Michael C.
    Chang, Lee-Shing
    McGuire, Darren K.
    Plutzky, Jorge
    Aroda, Vanita R.
    Vaduganathan, Muthiah
    JAMA CARDIOLOGY, 2020, 5 (10) : 1182 - 1190
12345